Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 115Recruiting 40Unknown 39Terminated 28Active not recruiting 8Withdrawn 3Suspended 2Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Leukemia, Myeloid, Acute 13Neoplasms 12Neoplasm Metastasis 9Melanoma 7Prostatic Neoplasms 6Ovarian Neoplasms 6Myelodysplastic Syndromes 6Breast Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Glioma 5Colorectal Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Hematologic Neoplasms 4Glioblastoma 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumors 2Solid Tumor 2Sarcoma 2Osteosarcoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, B-Cell 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Suspended × Solid Tumor × Clear all
NCT04381806 2026-05-22

Phase I Study in Advanced Malignancies With 5-ALA

Fox Chase Cancer Center

Phase 1 Suspended
130 enrolled
Other solid neoplasm

Solid Tumor

NCT05938296 2025-11-19

oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Binhui Biopharmaceutical Co., Ltd.

Phase 1 Suspended
29 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡